The Venture Codex Logo

The Venture Codex

Overview

Venture capital firm focused on healthcare and pharmaceuticals.

Founded

2017

Deals ยท 12mo

0

Stage focus

Series A
Series B

Geographic focus

China
United States

Sector focus

Financial Services
Health Care

Investment portfolio

2rounds
NAMEDATESIZE
Rona Therapeutics
Apr 2022Participated
$33 MSeries A
Regor Therapeutics
Feb 2021Participated
$90 MSeries B
Rona Therapeutics
Apr 2022Participated
$33 MSeries A
Regor Therapeutics
Feb 2021Participated
$90 MSeries B
2
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Lanting Capital: 2 funding rounds are recorded in the selected participation categories.All available history.
Lanting Capital: 2 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A01
Series B01

Monthly Deal Activity

Lanting Capital: 2 deals are recorded across 69 months.All available history.
Lanting Capital: 2 deals are recorded across 69 months. All available history
MonthDeals
Feb '211
Mar '210
Apr '210
May '210
Jun '210
Jul '210
Aug '210
Sep '210
Oct '210
Nov '210
Dec '210
Jan '220
Feb '220
Mar '220
Apr '221
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Lanting Capital: Health & Life Sciences is the largest displayed sector by deal count (2 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Lanting Capital: Health & Life Sciences is the largest displayed sector by deal count (2 deals). All available history
SectorDeals
Health & Life Sciences2

Deal Size Distribution

Lanting Capital: 2 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Lanting Capital: 2 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M0
$25M-$50M1
$50M-$100M1
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Lanting Capital: United States has the largest recorded deal count among the displayed regions (1 deals).All available history.

Top 2 of 2 regions; European countries are grouped as Europe.

Lanting Capital: United States has the largest recorded deal count among the displayed regions (1 deals). All available history
RegionDeals
United States1
China1
Lanting Capital: 6 co-investors are shown, with Lilly Asia Ventures sharing 2 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Lanting Capital: 6 co-investors are shown, with Lilly Asia Ventures sharing 2 recorded deals. All available history
Co-investorShared deals
Lilly Asia Ventures2
CMB International1
Fontus Capital1
Loyal Valley Capital1
Platanus1
TF Capital1

Investment Strategy

Lanting Capital: Led accounts for 0% and participating for 100% of round participation.All available history.
Lanting Capital: Led accounts for 0% and participating for 100% of round participation. All available history
CategoryDeals (count)Share (%)
Led00%
Participating2100%
Lanting Capital: Single-lead accounts for 0% and co-led for 0% of lead dynamics.All available history.
Lanting Capital: Single-lead accounts for 0% and co-led for 0% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead00%
Co-led00%

Lead dynamics requires at least one led deal in this range

Team

Amy Xu

Investment Director

Ethan Wu

Chief Executive Officer

Marc Roualet

Chief Legal Director